The study was conducted in partnership with Abera Bioscience, a platform and vaccine developer with over 30 years of research in the medical, molecular and microbiological fields. Both formulations ...

The collaboration is in line with Orexo's (ORXOY) strategy to broaden the use of its powder-based drug delivery technology AmorphOX ®. Abera is a developer of mucosal vaccines and has several ...

Abera Bioscience and Orexo have entered a partnership to develop and test the powder formulations of the former’s vaccine candidates against influenza, leveraging Orexo's AmorphOX technology. The ...

Researchers conducted a Phase III trial to test the 100-year-old Bacillus Calmette-Gu rin (BCG) vaccine in people with type 1 diabetes during the COVID-19 pandemic. In new research, investigators at ...

How can a tuberculosis vaccine also treat cancer—and potentially make other immunotherapies more effective? That’s the question researchers at Memorial Sloan Kettering Cancer Center (MSK) and Weill ...